MAZZONI, ALESSIO
 Distribuzione geografica
Continente #
NA - Nord America 1.787
EU - Europa 1.213
AS - Asia 271
SA - Sud America 3
AF - Africa 2
Totale 3.276
Nazione #
US - Stati Uniti d'America 1.781
PL - Polonia 395
IT - Italia 290
IE - Irlanda 218
SE - Svezia 164
HK - Hong Kong 121
CN - Cina 74
JO - Giordania 49
RU - Federazione Russa 45
GB - Regno Unito 25
DE - Germania 23
CH - Svizzera 18
FI - Finlandia 9
IN - India 8
UA - Ucraina 8
VN - Vietnam 8
BE - Belgio 6
ES - Italia 6
SG - Singapore 6
CA - Canada 5
BO - Bolivia 3
ID - Indonesia 2
NL - Olanda 2
FR - Francia 1
IR - Iran 1
IS - Islanda 1
KR - Corea 1
LI - Liechtenstein 1
MU - Mauritius 1
MX - Messico 1
RO - Romania 1
SC - Seychelles 1
TR - Turchia 1
Totale 3.276
Città #
Warsaw 395
Fairfield 261
Dublin 215
Ashburn 205
Chandler 202
Woodbridge 132
Cambridge 104
Seattle 95
Houston 93
Ann Arbor 79
Altamura 77
Lawrence 75
Hong Kong 73
Wilmington 65
Florence 62
Beijing 53
Princeton 49
Moscow 45
New York 30
Boston 29
Buffalo 28
San Diego 23
Medford 19
Washington 19
Bern 18
Bremen 16
Boardman 10
Milan 7
Sesto Fiorentino 7
Shanghai 7
Andover 6
Barcelona 6
Brussels 6
Dong Ket 6
Sant'elpidio A Mare 6
Siena 6
Falls Church 5
Nanjing 5
Redmond 5
Singapore 5
Campi Bisenzio 4
London 4
Napoli 4
Phoenix 4
West Jordan 4
Jacksonville 3
La Paz 3
Luni 3
Pisa 3
Prato 3
Redwood City 3
Toronto 3
Acton 2
Avellino 2
Castelliri 2
Cedar Knolls 2
Chengdu 2
Corner Brook 2
Fiesole 2
Formigine 2
Hillsboro 2
Laurel 2
Lucca 2
Menlo Park 2
Montepiano 2
Norwalk 2
Perugia 2
Pune 2
Rome 2
Salerno 2
San Giovanni Valdarno 2
Abenberg 1
Arezzo 1
Bari 1
Calenzano 1
Catanzaro 1
Centro 1
Chennai 1
Chicago 1
Cislago 1
Elmendorf 1
Fontebuona 1
Guadalajara 1
Hangzhou 1
Helsinki 1
Henderson 1
Incisa 1
Kilburn 1
Leawood 1
Mahé 1
Modena 1
Monmouth Junction 1
Montecatini Terme 1
Monteriggioni 1
New Bedfont 1
Padova 1
Prescot 1
Reykjavik 1
San Mateo 1
Santa Clara 1
Totale 2.657
Nome #
Mesenchymal stem cells are enriched in head neck squamous cell carcinoma, correlates with tumour size and inhibit T-cell proliferation 248
Chitinase 3-like-1 is produced by human Th17 cells and correlates with the level of inflammation in juvenile idiopathic arthritis patients 238
Th1-induced CD106 expression mediates leukocytes adhesion on synovial fibroblasts from juvenile idiopathic arthritis patients 206
Distinctive features of classic and non-classic (Th17-derived) human Th1 cells. 121
Human circulating group 2 innate lymphoid cells can express CD154 and promote IgE production 115
Immunosuppressive Activity of Abatacept on Circulating T Helper Lymphocytes from Juvenile Idiopathic Arthritis Patients 110
Musculin inhibits human T helper 17 cell response to interleukin 2 by controlling STAT5B activity 108
IL-4-induced gene 1 maintains high Tob1 expression that contributes to TCR unresponsiveness in human T helper 17 cells. 107
Th17 and Th1 lymphocytes in oligoarticular juvenile idiopathic arthritis 107
Biologicals targeting type 2 immunity: Lessons learned from asthma, chronic urticaria and atopic dermatitis 101
Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study 97
Demethylation of the RORC2 and IL17A in Human CD4+ T Lymphocytes Defines Th17 Origin of Nonclassic Th1 Cells. 96
Cell-mediated and humoral adaptive immune responses to SARS-CoV-2 are lower in asymptomatic than symptomatic COVID-19 patients 83
Biological and clinical significance of T helper 17 cell plasticity 81
Omalizumab dampens type 2 inflammation in a group of long-term treated asthma patients and detaches IgE from FcεRI 80
Eomes controls the development of Th17-derived (non-classic) Th1 cells during chronic inflammation 76
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition) 73
T Cell Response Toward Tissue-and Epidermal-Transglutaminases in Coeliac Disease Patients Developing Dermatitis Herpetiformis 72
The central role of the nasal microenvironment in the transmission, modulation, and clinical progression of SARS-CoV-2 infection 69
Metabolomic/lipidomic profiling of COVID-19 and individual response to tocilizumab 68
Human T cells interacting with HNSCC-derived mesenchymal stromal cells acquire Tissue-Resident memory like properties 65
Prevalence of allergy and asthma in a rural community of children and adults in Bolivian Chaco 61
Pulmonary vascular improvement in severe COVID-19 patients treated with tocilizumab 58
Disseminated Mycobacterium xenopi in an Adult with IL-12Rβ1 Deficiency 54
Heterogeneous magnitude of immunological memory to SARS-CoV-2 in recovered individuals 49
Prompt Predicting of Early Clinical Deterioration of Moderate-to-Severe COVID-19 Patients: Usefulness of a Combined Score Using IL-6 in a Preliminary Study 49
Quantitative and qualitative alterations of circulating myeloid cells and plasmacytoid DC in SARS-CoV-2 infection 46
First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in subjects who have recovered from COVID-19 44
Human T-cell cloning by limiting dilution 43
AIDS patient with severe T cell depletion achieved control but not clearance of SARS-CoV-2 infection 42
Impaired response to first SARS-CoV-2 dose vaccination in myeloproliferative neoplasm patients receiving ruxolitinib 40
Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) 37
Plasticity and regulatory mechanisms of human ILC2 functions 36
Antigen-driven PD-1+TOX+BHLHE40+ and PD-1+TOX+EOMES+ T lymphocytes regulate juvenile idiopathic arthritis in situ 35
SARS-CoV-2 Spike-Specific CD4+ T Cell Response Is Conserved Against Variants of Concern, Including Omicron 33
Th17 lymphocyte-dependent degradation of joint cartilage by synovial fibroblasts in a humanized mouse model of arthritis and reversal by secukinumab 31
Il4i1 is expressed by head–neck cancer-derived mesenchymal stromal cells and contributes to suppress t cell proliferation 31
Clinical and Immunological Features of SARS-CoV-2 Breakthrough Infections in Vaccinated Individuals Requiring Hospitalization 30
Hallmarks of immune response in COVID-19: Exploring dysregulation and exhaustion 30
Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent 28
SARS-CoV-2 infection and vaccination trigger long-lived B and CD4+ T lymphocytes: implications for booster strategies 28
The dual function of ILC2: From host protection to pathogenic players in type 2 asthma 24
Serum NMR Profiling Reveals Differential Alterations in the Lipoproteome Induced by Pfizer-BioNTech Vaccine in COVID-19 Recovered Subjects and Naïve Subjects 21
Long-term SARS-CoV-2 Asymptomatic Carriage in an Immunocompromised Host: Clinical, Immunological, and Virological Implications 20
COVID-19 in a kidney transplant recipient after mRNA-based SARS-CoV-2 vaccination 20
Study of signal transduction pathways by phospho-protein evaluation 20
Alarming inflammation: The TGFβ1–Nrp1 pathway upregulates the IL-33 axis in lung ILC2s 19
Variants Disrupting CD40L Transmembrane Domain and Atypical X-Linked Hyper-IgM Syndrome: A Case Report With Leishmaniasis and Review of the Literature 19
Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent 18
Clonally expanded PD-1-expressing T cells are enriched in synovial fluid of juvenile idiopathic arthritis patients 16
Fourth Dose of mRNA COVID-19 Vaccine Transiently Reactivates Spike-Specific Immunological Memory in People Living with HIV (PLWH) 15
T-Helper Cells, Methods and Protocols. Series Methods in Molecular Biology 14
Musculin does not modulate the disease course of Experimental Autoimmune Encephalomyelitis and DSS colitis 12
Optimization of the diagnosis and characterization of gibberellin-regulated protein sensitization: An Italian cohort study 10
Disseminated nocardiosis and anti-GM-CSF antibodies 10
Prompt Predicting of Early Clinical Deterioration of Moderate-to-Severe COVID-19 Patients: Usefulness of a Combined Score Using IL-6 8
Bendamustine impairs humoral but not cellular immunity to SARS-CoV-2 vaccination in rituximab-treated B-cell lymphoma-affected patients 5
Presentation and progression of MPO-ANCA interstitial lung disease 3
T lymphocytes-related cell network in the pathogenesis of juvenile idiopathic arthritis: a key point for personalized treatment 1
Totale 3.381
Categoria #
all - tutte 12.394
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.394


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019134 0 0 0 0 0 0 0 0 0 28 55 51
2019/2020537 27 30 15 32 77 54 60 68 57 57 48 12
2020/2021534 19 33 30 107 28 56 16 39 40 91 51 24
2021/2022381 8 25 38 8 17 20 11 32 51 17 60 94
2022/20231.033 85 244 56 66 54 172 128 59 107 9 25 28
2023/2024493 14 41 74 35 38 122 25 89 9 46 0 0
Totale 3.381